Vaxcyte to Present at 2021 Cantor Virtual Global Healthcare Conference

NEXT STORY
Relay & Fio Announce Execution of Definitive Agreement for Malaria Deployment
PREV STORY
Inventiva announces FDA decision that Fast Track designation granted to lanifibranor in NASH encompasses the treatment of NASH with compensated cirrhosis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Positive Interim Results of CHOICE-01 Study Evaluating Coherus’ and Junshi Biosciences’ Toripalimab for First Line Treatment of Non-Small Cell Lung Cancer Presented at World Conference on Lung Cancer

author_avatar
NASDAQ Market News

NewLink Genetics to Host Its Second Quarter 2018 Financial Results Conference Call on July 31, 2018

AMES, Iowa, July 10, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that ...

author_avatar
NASDAQ Market News

Novartis presents new Kisqali® data showing longest median overall survival ever reported in HR+/HER2- advanced breast cancer

author_avatar
NASDAQ Market News